03.11.2014 18:06:13
|
MannKind Loss Narrows
(RTTNews) - MannKind Corp (MNKD), a development stage biopharmaceutical company, Monday reported third-quarter net loss of $36.5 million or $0.09 per share compared with a loss of $50.8 million or $0.17 per share last year.
Analysts polled by Thomson Reuters estimated earnings of $0.01 per share on revenues of $51.6 million for the quarter. Analysts' estimates typically exclude special items.
Expenses for the quarter were lower at $38.3 million compared with $44.8 million last year.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu MannKind Corp.mehr Nachrichten
Keine Nachrichten verfügbar. |